Find your path to Mittie
279 people in our graph share verified history with Mittie — schools, employers, funds. One of them is your warm intro.
David CoatsunlockedMittie: together at Princeton University (1984–1986)
×2Mittie: together at Princeton University
Mittie: together at Harvard Medical School
Mittie: together at Aro Biotherapeutics
About
Research physician with over 20 years of pharma and biotech experience and numerous clinical development leadership roles. Most recently Chief Medical Officer at Aro Biotherapeutics; previously held senior immunology and therapeutic area head positions at CSL Behring, Shire, Flexion, and Alexion, advancing assets across immune-mediated and orphan disease indications.
Experience
- Cullinan TherapeuticsIndependent Board Membercurrent2025 — present
- Avalo TherapeuticsChief Medical Officercurrent2024 — presentWayne, PA
- Santa Ana Bio, Inc.Independent Board Membercurrent2023 — present
- Aro BiotherapeuticsChief Medical Officer2021 — 2024Philadelphia, Pennsylvania, United States
- DICE Therapeutics (acquired by Eli Lilly & Co.)Independent Board Member2022 — 2023
- CSL BehringVice President, Group Head Immunology and Inflammation2017 — 2021King of Prussia, PA
- ShireVice President, Global Development Lead2016 — 2017
- Flexion TherapeuticsVice President, Clincal Research2015 — 2016Burlington, MA
- Alexion PharmaceuticalsSenior Medical Director2012 — 2015Cambridge, MA
- CentocorDirector Janssen R&D, Clinical Immunology2009 — 2012Spring House, PA
- Centocor R&DAssociate Director2006 — 2009Chesterbrook, PA
- Tulane University School of MedicineAssistant Professor of Clinical Medicine2002 — 2006New Orleans, LA
- Harvard Medical SchoolInstructor in Medicine1996 — 1999
Skills & more
Clinical Trials26Medical Writing5Lifesciences3Biotechnology20R&D13Neurology3Immunology30Medicine16Drug Development14Clinical Research14Healthcare2Clinical Development18
+7 more
BiomarkersRheumatologyNeuroscienceMedical AffairsOncologyLife SciencesResearch and Development (R&D)From Mittie's professional profile.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Aaron Kantoff
Managing Partner at Scion Life Sciences
Amy Conrad
Senior Events Manager at Volta Labs
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garrett Lauderdale
Vice President at Idea of La Crosse
Frequently asked questions
- Who is Mittie Doyle?
- Research physician with over 20 years of pharma and biotech experience and numerous clinical development leadership roles. Most recently Chief Medical Officer at Aro Biotherapeutics; previously held senior immunology and therapeutic area head positions at CSL Behring, Shire, Flexion, and Alexion, advancing assets across immune-mediated and orphan disease indications.
- Where does Mittie Doyle work?
- Mittie Doyle is Chief Medical Officer at Avalo Therapeutics.
- Where did Mittie Doyle go to school?
- Mittie Doyle studied at Harvard Medical School (Fellowship - Brigham and Women's Hospital, Rheumatology and Immunology); Harvard Medical School - Massachusetts General Hospital (Internal Medicine Residency Program); Yale School of Medicine (Doctor of Medicine (MD)).
Same school
Also attended Harvard Medical School331
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 325 more
Also attended Harvard Medical School - Massachusetts General Hospital15
Barry SteinVice President, Chief Clinical Innovation Officer and Chief Medical Informatics Officer at Flare Capital PartnersHagai Marmor-KolletAssociate at aMoonJeno GyurisPartner at Cure VenturesBill FristCo-Founder and Partner at Frist Cressey VenturesAsh ZenoozVenture Partner at Aegis VenturesBill Frist, M.D.Co-Founder and Partner at Frist Cressey Ventures
+ 9 more
Also attended Princeton University1,000
Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordCat WuInvestor at Index VenturesAndrewAdvisor at Clear Ventures
+ 994 more
Shared employers
Also worked at Cullinan Therapeutics7
Kristen LaguerreExecutive Partner at MPM BioImpactTony RosenbergManaging Director at MPM BioImpactDavid MeekChief Executive Officer at Bluebird BioMary Kay FentonChief Financial Officer at Cullinan TherapeuticsJennifer MichaelsonChief Scientific Officer at Cullinan TherapeuticsCorinne SavillChief Business Officer at Cullinan Therapeutics
+ 1 more
Also worked at Flexion Therapeutics7
Heath LukatchPartner at Novo HoldingsRahul BallalExecutive Officer, Director at Mediar TherapeuticsKerri-Ann MillarExecutive Officer at SyncromuneLISA DAVIDSONExecutive Officer at FractylDan DeardorfCEO at GlycologixKerry WentworthChief Regulatory Officer at Nuvation Bio
+ 1 more
Also worked at Alexion Pharmaceuticals26
Abbie CelnikerInvestor at Third Rock VenturesSeung Hyun Moon, MD, MPAVenture Partner at Adelphi Ventures Management, LlcJustin WilliamsPrincipal at Seae VenturesRomesh SubramanianVenture Partner at Scion Life SciencesChristina BroomesCommercial Advisor at 2Flo VenturesJohn ReyndersChief Data Scientist & Venture Partner at Iaso Ventures
+ 20 more
Also worked at Centocor13
Marian NakadaVice President, Venture Investments at JJDCGregory HarrimanPartner at BioAdvanceMarkwin VeldersAdvisory Committee member at Curie CapitalVenkat KokaInvestment Committee at PS27 VenturesRamon BenetInvestor at Sky VenturesEllen ReillyChief Executive Officer at Sware
+ 7 more